RBR-4n5mkh招募中2 期
Evaluation of the efficacy and security of oral Estrogen use in the treatment of female patients with Acromegaly
Instituto Estadual do Cerebro Paulo Niemeyer0 个研究点开始时间: 2020年3月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 50Y（—）
- 性别
- Female
入选标准
- •Patients of childbearing age who had a desire for contraception and who agreed to use oral contraceptives were included. All participants were uncontrolled with IGF-I concentration above the upper limit of normal range (ULNR) for age, and with a random GH level above 1 ng/ml.
排除标准
- •The study exclusion criteria included contraindications to oral contraceptive use such as cerebrovascular or coronary artery disease; history of deep vein thrombosis, pulmonary embolism, or congestive heart failure; untreated or uncontrolled hypertension (relative contraindication: systolic blood pressure 140-159 or diastolic 90-99; absolute: ? 160mmHg or ? 100mmHg); breast cancer; estrogen-dependent neoplasia, undiagnosed abnormal genital bleeding, known or suspected pregnancy, benign or malignant liver tumors; active liver disease; smoking; diabetes with vascular complications; renal failure with glomerular filtration rate below 30ml/min.
研究者
相似试验
已完成
4 期
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
尚未招募
Unknown
Study to evaluate the effectiveness and safety of drug- oral tofacitinib in patients with Parthenium dermatitisCTRI/2023/10/058514AIIMS, New Delhi
尚未招募
3 期
Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childreCTRI/2024/02/063274IMS and SUM Hospital
尚未招募
不适用
To compare different iron therapy for anemic pregnant womeCTRI/2020/04/024548Dr Shreedevi Kori
进行中（未招募）
不适用
Eficacia y seguridad de una administración oral diaria de S06911 (combinación fija de ranelato de estroncio 2g / vitamina D3 1000UI) en la deficiencia de vitamina D para el tratamiento de la osteoporosis en mujeres postmenopáusicas y hombres Estudio internacional, de fase III, prospectivo, de 12 meses de duración en abierto con un grupo de tratamiento. The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D deficiency in the treatment of osteoporotic postmenopausal women and men. A 12 month, prospective, open labelled, one treatment group international phase III study.Osteoporosis en hombres y mujeres postmenopáusicasMedDRA version: 9Level: LLTClassification code 10031283Term: Osteoporosis fractureMedDRA version: 9Level: LLTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2009-014270-18-ESaboratorios Servier S.L.60